Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Grzegorzewska AE | [Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease]. | 2007 | Pol. Arch. Med. Wewn. | pmid:17722476 |
Drzewiecki J | Excretion of D-glucaric acid and metabolism of salicylamide in man: the effect of phenobarbital-produced enzymatic induction. | 1977 Jul-Aug | Pol J Pharmacol Pharm | pmid:905203 |
Horváth T et al. | Investigation of biotransformation capacity in patients with chronic liver diseases by pharmacokinetic methods: experimental trials. | 1984 Jul-Aug | Pol J Pharmacol Pharm | pmid:6396596 |
Chaudhuri RR et al. | Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. | 2010 | PLoS ONE | pmid:20098708 |
Bidossi A et al. | A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae. | 2012 | PLoS ONE | pmid:22428019 |
Galindo P et al. | Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation. | 2012 | PLoS ONE | pmid:22427863 |
Barbieri C et al. | Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients. | 2016 | PLoS ONE | pmid:26939055 |
Connor JR et al. | Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. | 2015 | PLoS ONE | pmid:25973894 |
Italia K et al. | Hydroxyurea could be a good clinically relevant iron chelator. | 2013 | PLoS ONE | pmid:24349400 |
Ruiz JC et al. | Evidence for reductive genome evolution and lateral acquisition of virulence functions in two Corynebacterium pseudotuberculosis strains. | 2011 | PLoS ONE | pmid:21533164 |
Smith AA et al. | The CanOE strategy: integrating genomic and metabolic contexts across multiple prokaryote genomes to find candidate genes for orphan enzymes. | 2012 | PLoS Comput. Biol. | pmid:22693442 |
Saluk-Juszczak J | A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and D-glucono-1,4-lactone in a human blood platelet model. | 2010 | Platelets | pmid:20873960 |
Sudan C et al. | Ubiquitous presence of beta-glucuronidase (GUS) in plants and its regulation in some model plants. | 2006 | Planta | pmid:16652220 |
Strack D et al. | Enzymic synthesis of caffeoylglucaric Acid from chlorogenic Acid and glucaric Acid by a protein preparation from tomato cotyledons. | 1987 | Plant Physiol. | pmid:16665274 |
Do PT et al. | The influence of fruit load on the tomato pericarp metabolome in a Solanum chmielewskii introgression line population. | 2010 | Plant Physiol. | pmid:20841452 |
Fior S and Gerola PD | Impact of ubiquitous inhibitors on the GUS gene reporter system: evidence from the model plants Arabidopsis, tobacco and rice and correction methods for quantitative assays of transgenic and endogenous GUS. | 2009 | Plant Methods | pmid:20042078 |
Centeno DC et al. | Malate plays a crucial role in starch metabolism, ripening, and soluble solid content of tomato fruit and affects postharvest softening. | 2011 | Plant Cell | pmid:21239646 |
Araki T et al. | Clinical efficacy of two forms of intravenous iron--saccharated ferric oxide and cideferron--for iron deficiency anemia. | 2012 | Pharmazie | pmid:23346769 |
Arató M and Varadi A | On the possible role of enzyme induction in cases of resistancy to chlorpromazine treatment. | 1977 | Pharmakopsychiatr Neuropsychopharmakol | pmid:616930 |
Sane R et al. | Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate. | 2007 | Pharmacotherapy | pmid:17381390 |
Pai AB et al. | Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. | 2007 | Pharmacotherapy | pmid:17316146 |
Barot BS et al. | Physicochemical and structural characterization of iron-sucrose formulations: a comparative study. | 2014 | Pharm Dev Technol | pmid:23701359 |
PERSOONIAL Reflections. | 2009 | Persoonia | pmid:20198167 | |
Hörl WH | Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. | 2001 Sep-Oct | Perit Dial Int | pmid:11757843 |
Dittrich E et al. | Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. | 2002 Jan-Feb | Perit Dial Int | pmid:11929146 |
Li H and Wang SX | Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. | 2008 Mar-Apr | Perit Dial Int | pmid:18332450 |
Prakash S et al. | Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. | 2001 May-Jun | Perit Dial Int | pmid:11475345 |
Levy G et al. | Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. | 1975 | Pediatrics | pmid:1134883 |
Pollak A et al. | Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. | 2001 | Pediatrics | pmid:11134438 |
Talafant E et al. | Glucaric acid excretion as index of hepatic glucuronidation in neonates after phenobarbital treatment. | 1975 | Pediatr. Res. | pmid:1134846 |
Talafant E et al. | Negative feedback control of neonatal serum creatine and increased urinary creatinine excretion after enzyme-inducing drugs. | 1977 | Pediatr. Res. | pmid:887306 |
Gourley GR et al. | The effect of saccharolactone on rat intestinal absorption of bilirubin in the presence of human breast milk. | 1989 | Pediatr. Res. | pmid:2704588 |
Galutira PJ and Del Rio M | Understanding renal posttransplantation anemia in the pediatric population. | 2012 | Pediatr. Nephrol. | pmid:22086345 |
Hörl WH | Iron therapy for renal anemia: how much needed, how much harmful? | 2007 | Pediatr. Nephrol. | pmid:17206511 |
Schröder CH | The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. | 2003 | Pediatr. Nephrol. | pmid:12750985 |
Auerbach M | Should intravenous iron be upfront therapy for iron deficiency anemia? | 2011 | Pediatr Blood Cancer | pmid:21298731 |
Crary SE et al. | Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. | 2011 | Pediatr Blood Cancer | pmid:21298748 |
Micheletti C et al. | [Enzymatic induction during isoniazid therapy (author's transl)]. | 1979 | Pathol. Biol. | pmid:392418 |
Roth B et al. | [Excretion of D-glucaric-acid in newborns with non-hemolytic hyperbilirubinemia after phenobarbital treatment (author's transl)]. | 1977 | Padiatr Padol | pmid:904946 |
Berlin I et al. | [The effect of contraceptives on serum lipids, gamma glutamyl transpeptidase and D-glucaric acid elimination]. | 1980 | Orv Hetil | pmid:6110202 |
Gachályi B et al. | [Effect of alpha methyldopa on the mixed oxygenase system of the liver in man]. | 1979 | Orv Hetil | pmid:372883 |
Aime S et al. | para-Hydrogenation of unsaturated moieties on poly(lysine) derived substrates for the development of novel hyperpolarized MRI contrast agents. | 2005 | Org. Biomol. Chem. | pmid:16240012 |
Kowalczyk MC et al. | Modulation of biomarkers related to tumor initiation and promotion in mouse skin by a natural β-glucuronidase inhibitor and its precursors. | 2011 | Oncol. Rep. | pmid:21687956 |
Franco G and Fonte R | Advances in evaluating liver response to operating theatre work: urinary D-glucaric acid as an index of effect. | 1994 | Occup Med (Lond) | pmid:8167312 |
Olas B et al. | Protective effects of D-glucaro 1,4-lactone against oxidative/nitrative modifications of plasma proteins. | 2007 | Nutrition | pmid:17234507 |
Kim Y et al. | Combination of erythritol and fructose increases gastrointestinal symptoms in healthy adults. | 2011 | Nutr Res | pmid:22118754 |
Gonçalves P et al. | The effect of high glucose on SERT, the human plasmalemmal serotonin transporter. | 2008 | Nutr Neurosci | pmid:19000377 |
Saluk-Juszczak J et al. | Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets. | 2008 | Nutr Metab Cardiovasc Dis | pmid:17933501 |
Gambini JP et al. | Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model. | 2011 | Nucl. Med. Biol. | pmid:21315281 |
Isnardi V et al. | Is [(99m)Tc]glucarate uptake mediated by fructose transporter GLUT-5? | 2012 | Nucl. Med. Biol. | pmid:23084044 |